|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.455 AUD | +3.59% |
|
-1.41% | -9.74% |
| 02-09 | Mesoblast Says JPMorgan Chase Becomes Substantial Holder; Shares Rise 6% | MT |
| 02-06 | ASX Biggest Losers | MT |
Company Valuation: Mesoblast Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,282 | 396.4 | 923.5 | 1,130 | 2,114 | 3,059 | - | - |
| Change | - | -69.07% | 132.95% | 22.34% | 87.09% | 44.72% | - | - |
| Enterprise Value (EV) 1 | 1,239 | 396.4 | 981.2 | 1,206 | 2,053 | 2,996 | 2,834 | 2,293 |
| Change | - | -68% | 147.49% | 22.87% | 70.3% | 45.92% | -5.39% | -19.1% |
| P/E ratio | -4.42x | -1.49x | -3.33x | -7.54x | -12.8x | -202x | 26.6x | 7.44x |
| PBR | - | - | 0.6x | 1.6x | 2.18x | 3.19x | 2.67x | 2.29x |
| PEG | - | 0.17x | 0.2x | 0.1x | 9.95x | 2.2x | -0x | 0x |
| Capitalization / Revenue | 125x | 26.7x | 80x | 130x | 80.2x | 17.3x | 8.4x | 4.32x |
| EV / Revenue | 121x | 26.7x | 84.9x | 139x | 77.9x | 16.9x | 7.78x | 3.24x |
| EV / EBITDA | -10.7x | -3.9x | -11x | -13.5x | -18.5x | 86.1x | 12.2x | 3.67x |
| EV / EBIT | -10.2x | -3.67x | -10.3x | -12.6x | -17x | 2,514x | 19.1x | 5.27x |
| EV / FCF | -8.36x | -4.14x | -10x | -16.8x | -26.5x | -293x | 16x | 5.57x |
| FCF Yield | -12% | -24.2% | -9.97% | -5.96% | -3.78% | -0.34% | 6.23% | 17.9% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.4476 | -0.4091 | -0.3412 | -0.1313 | -0.1296 | -0.0118 | 0.0891 | 0.3186 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 10.22 | 14.84 | 11.55 | 8.7 | 26.36 | 176.9 | 364.3 | 708.6 |
| EBITDA 1 | -115.9 | -101.6 | -89.11 | -89.14 | -111 | 34.78 | 233.1 | 625 |
| EBIT 1 | -121.9 | -107.9 | -95.44 | -96.02 | -120.8 | 1.191 | 148.3 | 435.4 |
| Net income 1 | -135.4 | -132.7 | -126.1 | -129.7 | -156.5 | -20.72 | 92.2 | 316.9 |
| Net Debt 1 | -42.95 | - | 57.66 | 75.75 | -60.77 | -63.28 | -224.9 | -766.1 |
| Reference price 2 | 1.980 | 0.610 | 1.135 | 0.990 | 1.655 | 2.370 | 2.370 | 2.370 |
| Nbr of stocks (in thousands) | 647,399 | 649,912 | 813,662 | 1,141,241 | 1,277,239 | 1,290,770 | - | - |
| Announcement Date | 30/08/21 | 30/08/22 | 30/08/23 | 28/08/24 | 28/08/25 | - | - | - |
1AUD in Million2AUD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -189.63x | 15.91x | 80.95x | - | 2.02B | |
| 36.2x | 5.26x | 17.62x | 0.95% | 46.82B | |
| 108.48x | 6.96x | 69.61x | -.--% | 39.16B | |
| 58.42x | 11.94x | 33.41x | 0.33% | 32.9B | |
| 26.51x | 2.79x | 11.94x | -.--% | 31.8B | |
| -17.45x | 4983.42x | -16.28x | -.--% | 18.85B | |
| 36.62x | 5.92x | 26.9x | -.--% | 15.27B | |
| Average | 8.45x | 718.88x | 32.02x | 0.21% | 26.69B | |
| Weighted average by Cap. | 45.80x | 508.77x | 28.36x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- MSB Stock
- Valuation Mesoblast Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition